Stellar Biotechnologies, Inc.·4

Mar 14, 8:21 PM ET

Chun Paul 4

4 · Stellar Biotechnologies, Inc. · Filed Mar 14, 2018

Insider Transaction Report

Form 4
Period: 2018-03-12
Chun Paul
Director
Transactions
  • Award

    Share Option (Right to Buy)

    2018-03-12+2,5002,500 total
    Exercise: $0.84Exp: 2025-03-12Common Shares (2,500 underlying)
Footnotes (1)
  • [F1]Option grant under the 2017 Incentive Compensation Plan, which shall vest as to one-third immediately, as to one-third on March 12, 2019 and as to the remaining one-third on September 12, 2019.

Documents

1 file
  • 4
    tv488524_4.xmlPrimary

    OWNERSHIP DOCUMENT